Evon Medics LLC
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2013-04-02
- Employees
- 11
- Market Cap
- -
- Website
- http://evonmedics.com
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)โข Click on a phase to view related trials
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)
- Conditions
- Chronic PainLow Back Pain
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Evon Medics LLC
- Target Recruit Count
- 220
- Registration Number
- NCT06671132
- Locations
- ๐บ๐ธ
Howard University, Washington, District of Columbia, United States
๐บ๐ธGlobal Pain Management LLC, Pasadena, Maryland, United States
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
- Conditions
- Opioid Use DisorderMethamphetamine-dependenceCocaine Use DisorderSubstance Use DisordersAlcohol Use Disorder
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Evon Medics LLC
- Target Recruit Count
- 300
- Registration Number
- NCT06434818
- Locations
- ๐บ๐ธ
Clinics of Dr. Edwin Chapman @ MHDG, Washington, District of Columbia, United States
๐บ๐ธHoward University, Washington, District of Columbia, United States
๐บ๐ธMaryland Treatment Center, Rockville, Maryland, United States
Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Networks Training for Treatment of Pain
- Conditions
- Chronic PainLow Back Pain
- First Posted Date
- 2024-01-23
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Evon Medics LLC
- Target Recruit Count
- 86
- Registration Number
- NCT06218407
- Locations
- ๐บ๐ธ
Howard University, Washington, District of Columbia, United States
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
- Conditions
- Mild Cognitive ImpairmentEarly Alzheimer's DiseaseMemory Impairment
- Interventions
- Drug: COTDrug: Sham
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Evon Medics LLC
- Target Recruit Count
- 200
- Registration Number
- NCT05122598
- Locations
- ๐บ๐ธ
Clinics of Dr. Edwin Chapman @ MHDG, Washington, District of Columbia, United States
๐บ๐ธFamily and Medical Counseling Service, Inc, Washington, District of Columbia, United States
๐บ๐ธHoward University (HU), Washington, District of Columbia, United States
Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder
- Conditions
- Opioid Use Disorder, ModerateOpioid Use Disorder, SevereNegative AffectivityWithdrawal SymptomsCraving
- Interventions
- Drug: Sham + TAUDrug: CBOT + TAU
- First Posted Date
- 2021-04-20
- Last Posted Date
- 2021-08-06
- Lead Sponsor
- Evon Medics LLC
- Target Recruit Count
- 190
- Registration Number
- NCT04850664
- Locations
- ๐บ๐ธ
Clinics of Dr. Edwin Chapman @ MHDG, Washington, District of Columbia, United States
๐บ๐ธFamily and Medical Counseling Service, Inc, Washington, District of Columbia, United States
๐บ๐ธHoward University, Washington, District of Columbia, United States